Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
My experience has been mostly positive. As with any start-up, there have been challenges. However, I do what I can to contribute positively and try not to get caught up in negativity. I feel more opps for dvlpm't into other roles and education would help with retention & job satisfaction.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Transparency & willingness to collaborate and help when needed.
Qu’est-ce qui vous rend le plus heureux au travail?
Making a difference in the life of a patient.
Pourquoi vous sentez-vous sous-évalué et qu’est-ce qui vous rassurerait par rapport à votre rémunération?
I was brought on board at less than my colleagues and have been in "making it up" mode ever since.
Quelles sont les meilleures choses à propos de votre équipe?
We are very supportive of each other and celebrate each other's successes. We also contribute to each other's success whenever possible.
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
That we are a start-up and are faced with challenges that require attention to overcome. I feel like I am making a positive contribution to the current and future success of the organization.
Other Employee Reviews for Karyopharm Therapeutics
×